SOPH
SOPHiA GENETICS S.A.
NASDAQ · CHHealthcareMedical - Healthcare Information Services
$6.33+7.84%
Price as of Jul 20, 2026
SOPH profitability
SOPHiA GENETICS S.A. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 67.3%
- EBITDA margin
- -81.4%
- EBIT margin
- -88.4%
- Net margin
- -99.7%
- Free cash flow margin
- -56.0%
Returns
- Return on equity
- -177.1%
- Return on assets
- -51.6%
- Return on invested capital
- -66.4%
- Asset turnover
- 0.51x
Cash efficiency
- Cash from operations
- -$42.1M
- Cash per share
- $0.91
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.